Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Marco Metra and Marianna Adamo.
Connection Strength

4.275
  1. June 2020 at a glance: focus on COVID-19, quality of life and comorbidities. Eur J Heart Fail. 2020 06; 22(6):917-918.
    View in: PubMed
    Score: 0.885
  2. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front Cardiovasc Med. 2021; 8:713560.
    View in: PubMed
    Score: 0.240
  3. March 2021 at a glance: focus on epidemiology, prevention and COVID-19. Eur J Heart Fail. 2021 03; 23(3):347-349.
    View in: PubMed
    Score: 0.233
  4. Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. Eur J Heart Fail. 2021 03; 23(3):486-488.
    View in: PubMed
    Score: 0.231
  5. Patient with heart failure: importance to treat valvular diseases. Eur Heart J Suppl. 2020 Dec; 22(Suppl Pt t):P38-P41.
    View in: PubMed
    Score: 0.230
  6. December 2020 at a glance: focus on COVID-19, comorbidities and palliative care. Eur J Heart Fail. 2020 12; 22(12):2173-2174.
    View in: PubMed
    Score: 0.229
  7. Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2020 Nov; 21(11):874-881.
    View in: PubMed
    Score: 0.228
  8. ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19. Eur Heart J. 2020 09 01; 41(33):3200.
    View in: PubMed
    Score: 0.225
  9. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Jun; 22(6):941-956.
    View in: PubMed
    Score: 0.223
  10. Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk? Eur Heart J. 2020 07 01; 41(32):3094.
    View in: PubMed
    Score: 0.223
  11. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 07 01; 5(7):819-824.
    View in: PubMed
    Score: 0.223
  12. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020 Jun; 22(6):957-966.
    View in: PubMed
    Score: 0.222
  13. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 05 14; 41(19):1821-1829.
    View in: PubMed
    Score: 0.220
  14. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail. 2019 02; 21(2):196-204.
    View in: PubMed
    Score: 0.200
  15. Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: early and midterm outcomes. EuroIntervention. 2017 Oct 13; 13(9):e1032-e1039.
    View in: PubMed
    Score: 0.184
  16. Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience. Int J Cardiol. 2017 May 01; 234:53-57.
    View in: PubMed
    Score: 0.176
  17. Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? Eur J Heart Fail. 2019 07; 21(7):852-861.
    View in: PubMed
    Score: 0.052
  18. EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis. J Cardiovasc Med (Hagerstown). 2019 Mar; 20(3):131-136.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.